In February 2017, it was announced that Hologic Inc (Nasdaq: HOLX), had acquired Cynosure (NASDAQ:CYNO) for a cash transaction. The firm ceased trading shortly thereafter. Very early after the founding of the firm, Cynosure was SBIR involved. The firm specialized in the manufacture of medical lasers for the treatment of various aesthetic conditions and disorders. Cynosure was leading developer and manufacturer of a broad array of light-based aesthetic and medical treatment systems. The company's products are used by physicans and those in the beauty business to provide a diverse range of treatment applications such as hair removal, skin rejuvenation and scar reduction, as well as the treatment of vascular lesions. A highly innovative company, Cynosure held numerous U.S. patents and markets over 14 different light based systems, representing advanced levels of solid-state, liquid and semiconductor laser technologies. The firm's products are used worldwide, with Cynsoure supporting customers in over 60 countries through wholly owned subsidiaries and global distributors. In 2013, it was announced that beauty treatment companies Cynosure Inc. (NASDAQ: CYNO) of Westwood and Burlington-based Palomar Medical Technologies Inc. (NASDAQ: PMTI) had signed a definitive agreement for Cynosure to acquire Palomar in a cash and stock transaction.
